Search results
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News via Yahoo News· 1 day agoAn FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared...
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
AOL· 1 day agoA U.S. Food and Drug Administration (FDA) panel rejected MDMA-based treatments for post-traumatic stress ...
Study: New type of psychotherapy helps treat chronic pain
United Press International via Yahoo News· 3 hours agoA new form of psychotherapy appears to work even better at treating chronic pain in older adults...
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
FierceBiotech· 1 day agoA week after an FDA committee declined to support an midomafetamine (MDMA) treatment for post-...
Many in San Diego County still suffer from COVID-related anxiety
U-T San Diego· 2 days agoAbout 238,000 adults in San Diego County suffer from a serious anxiety disorder resulting from their...
CT board approves cannabis to treat autism, female orgasmic difficulty disorder
The News-Times· 3 days agoState Department of Consumer Protection Commissioner Bryan T. Cafferelli this week thanked both the...
Does Your Mental Health Need a Boost? Get Started With These 25 Journal Prompts
Parade via AOL· 1 day agoJournaling can be a powerful and therapeutic way to address anxiety and other mental health ...
Marine Corps Museum Opens 'Respite Room' as New Way to Help Visitors Deal with PTSD
Military.com via Yahoo News· 2 days agoAt the National Museum of the Marine Corps in Virginia, there is now a quiet place for veterans to...
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
NPR· 1 day agoLast week, advisers to the Food and Drug Administration pored over shortcomings and missteps in the research and overwhelmingly rejected the evidence supporting MDMA as an effective
MDMA’s Future As A Treatment For PTSD Is In Question
Inverse· 3 days agoOn Tuesday, an expert panel advising the Food and Drug Administration (FDA) on the use of MDMA, or ecstasy, in combination with talk therapy to treat post-traumatic ...